GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vext Science Inc (XCNQ:VEXT) » Definitions » EV-to-Revenue

Vext Science (XCNQ:VEXT) EV-to-Revenue : 2.37 (As of Sep. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Vext Science EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Vext Science's enterprise value is C$107.23 Mil. Vext Science's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was C$45.16 Mil. Therefore, Vext Science's EV-to-Revenue for today is 2.37.

The historical rank and industry rank for Vext Science's EV-to-Revenue or its related term are showing as below:

XCNQ:VEXT' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.11   Med: 2.04   Max: 6.32
Current: 2.38

During the past 7 years, the highest EV-to-Revenue of Vext Science was 6.32. The lowest was 1.11. And the median was 2.04.

XCNQ:VEXT's EV-to-Revenue is ranked worse than
51.2% of 1004 companies
in the Drug Manufacturers industry
Industry Median: 2.27 vs XCNQ:VEXT: 2.38

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-26), Vext Science's stock price is C$0.245. Vext Science's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was C$0.22. Therefore, Vext Science's PS Ratio for today is 1.09.


Vext Science EV-to-Revenue Historical Data

The historical data trend for Vext Science's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vext Science EV-to-Revenue Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial 2.01 3.92 2.05 1.65 2.21

Vext Science Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.88 2.15 2.21 2.52 2.31

Competitive Comparison of Vext Science's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vext Science's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vext Science's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Vext Science's EV-to-Revenue falls into.



Vext Science EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Vext Science's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=107.233/45.155
=2.37

Vext Science's current Enterprise Value is C$107.23 Mil.
Vext Science's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$45.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vext Science  (XCNQ:VEXT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Vext Science's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.245/0.224
=1.09

Vext Science's share price for today is C$0.245.
Vext Science's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vext Science EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vext Science's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Vext Science Business Description

Traded in Other Exchanges
Address
4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company's expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing. The Company's operations consist of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the United States.
Executives
Caroline Marie-clothilde Williams Director

Vext Science Headlines

No Headlines